Find A Physician
More on Specifics of PGY-1 & 2
More on Specifics of PGY-1 & 2
Research and Clinical Trials
More on Specifics of PGY-1 & 2
More on Specifics of PGY-1 & 2
More on Specifics of PGY-1 & 2
Pharmacy at NYP
Specifics of PGY-1 & 2
The PGY-1 and PGY-2 Pharmacy Residency Programs are a structured learning experience intended to provide clinical, research and teaching experience in a challenging healthcare setting. Residents will have the opportunity to develop professional relationships with clinicians and patients as well as play an integral role in caring for patients.
Learning experiences usually range 3-6 weeks in length. The pharmacy resident is expected to attend and actively participate in daily work and attending rounds, pertinent medical didactic lectures or conferences, research and develop answers to drug information questions received from healthcare professionals, meet with his/her preceptor to discuss patient cases and/or topic discussion, and follow-up on pertinent issues.
The pharmacy resident is expected to interact with medical students, interns, residents, fellows, attendings, nursing and pharmacy staff. In addition, communication between residents and their patients, families, and caregivers is encouraged, when applicable.
The program timeline for completion of the 12-month residency is as follows:
Hospital, Departmental, Drug Distribution, Drug Information, Residency/RLS, Computer, Laboratory, Pharmacokinetics, Library, BLS, Project and Medical Use Evaluation (MUE) Selection
August - November: Rotations
Required Rotations, ACLS, Submission of Investigational Review Board (IRB) application for Research Project
ASHP Mid-Year Clinical Meeting, Research Project data collection, MUE data collection
January - June: Rotations
Required and Elective Rotations, Eastern States Residency Conference
Administrative Meetings, Formulary and Therapeutics Committee Meetings, Subcommittee Meetings, MUE, Research Project, Service Commitment, Weekend On-Call
Residency Advisory Committee (RAC)
The Residency Advisory Committee functions to guide the Program Directors in the development of the clinical, research and administrative teaching programs. The RAC addresses:
- Overall progress of each resident in the program
- Quality improvement for rotations, longitudinal experiences, and preceptors
- Special circumstances
The Residency Program Director (PGY-1) serves as chair of the RAC. The RAC has no authority regarding the residents or preceptors. The RAC's role is to provide advice and insight to the Residency Directors. The RAC will meet at a minimum quarterly throughout the year.
Residents will be invited to attend the beginning of each RAC meeting to discuss any issues they might have and provide feedback. One week prior to the meeting, residents will be asked to submit any issues they wish to discuss so that they may be added to the meeting agenda. Any final decisions will be made only after the RAC has had time to thoroughly discuss the issues and may not necessarily be during that meeting.
- Anastasia Anamisis, Pharm.D., BCPS, PGY-2 Solid Organ Transplantation Director
- Rick Fichtl, Pharm.D., Director, Drug Use Policy and Acquisition
- Adrianne Hewryk, Pharm.D., PGY-1 Residency Program Director
- Amy Dzierba, Pharm.D. BCPS, PGY-2 Critical Care Residency Program Director
- Cindy Ippoliti, Pharm.D., Clinical Preceptor, NYPH-WC
- Christine Kubin, Pharm.D., BCPS, PGY-2 Infectious Diseases Residency Program Director
- Liz Ramos, Pharm.D., Clinical Preceptor, NYPH-WC
- Demetra Tsapepas, Pharm.D., Clinical Preceptor, NYPH-C
The resident will complete a project that will be presented at the Eastern States Residency and Preceptors Conference in May. This project can be of original research, a problem-solving exercise or development, enhancement or evaluation of some aspect of pharmacy services. A publication quality manuscript of the residency project must be submitted to the Residency Director prior to completion of the program.
A list of potential research project topics will be available; however residents are strongly encouraged to pursue individual interests. Project topics are subject to approval by the Residency Director and the Residency Advisory Committee.
The project preceptor and resident will complete a research project summative evaluation form on a quarterly basis which will be submitted to the Residency Program Director as part of the quarterly evaluation.
The program will provide many opportunities for residents to share findings from their patient care experiences, the literature and their own research through structured case presentations, attendance at conferences, seminars and other avenues for professional interaction.
Formal Patient Case Presentations
PGY-1 and PGY-2 pharmacy residents are required to prepare and present two formal case presentations during their residency. Residents are required to attend all formal case presentations. The topics for the presentations should be chosen based on actual patients followed during current or recent rotations. The goal of a case presentation is to discuss the drug therapy of a rare disease state or to discuss a controversial drug therapy issue of a common disease state related to a particular patient case. Review of the disease state or controversy must be well-researched through utilization of primary literature sources.
PGY-1 and PGY-2 pharmacy residents are required to prepare and present one formal seminar during the residency program, presented at least once at each campus. Residents are required to attend all resident seminars at the campus where their rotation is at that time. All residents are required to apply for ACPE (American Council on Pharmacy Education) certification of their seminar for continuing education credit. The Drug Information Center will assist in the application process and with the duplication of the program publicity materials as well as registration and evaluation documents.
The goal of the seminar is to expand the resident's communication skills and presentation techniques. The seminar topic will be chosen by the resident, with guidance from the Residency Program Director and should involve a therapeutic or practice management controversy, clinical or practice management research or review of a specific therapeutic area.
The objectives of the Resident Seminar include the following:
- Critical evaluation of the literature
- Enhancement of presentation, teaching and communication skills
- Provision of continuing education for pharmacists and other health care providers
- Development of skills in responding to audience questions and comments
- Familiarization with audiovisual equipment and techniques
PGY-1 and PGY-2 pharmacy residents will present two or three formal journal clubs during the residency year. This experience is designed to help residents evaluate and appraise medical literature through the evaluation of statistical methods used, the statistical significance and clinical significance of study results as well as the impact on current and future practice. Residents are required to attend all journal clubs presented by their fellow residents and any others recommended by their rotation preceptor.
Resident Services and Educational Activities
The resident is required to successfully complete each of the following activities in order to become eligible to complete the residency program.
Basic Cardiac Life Support (BLS) & Advanced Cardiac Life Support (ACLS)
Certification is required of all PGY-1 and PGY-2 critical care pharmacy residents. Optional for PGY-2 Infectious Diseases and Solid Organ Transplantation pharmacy residents.
Conference Attendance (Perpetual)
Residents are required to attend all educational conferences recommended by their rotation preceptor.
Residents are required to attend monthly ACPE-accredited Pharmacy Grand Rounds. Attendance requirements may be modified at the discretion of the individual preceptor.
New York-Presbyterian also provides numerous educational programs that the resident may attend. These optional experiences are available through various departments within the hospital or medical schools. These activities are subject to approval by the individual preceptor.
Resident Discussion Series
The Resident Discussion Series is a forum where residents learn about identified topics of interest in pharmacy practice. These discussions are designed to aid in the professional development of the residents and are scheduled to address timely concerns that the residents will encounter over the residency year.
As a portion of the practice management goals of the program, resident attendance at all Formulary and Therapeutics meetings and Joint Administrative meetings is mandatory. Residents will also attend any additional administrative meetings or subcommittee meetings deemed appropriate by the individual preceptor.
In addition to attending all Formulary and Therapeutics Committee meetings, PGY-1 pharmacy residents will become members of Subcommittees of the Formulary and Therapeutics Committee – Medication Safety and Medication Safety Informatics. This is a longitudinal learning experience and residents are expected to attend all subcommittee meetings, formulate meeting agendas and minutes, and participate in subcommittee activities as deemed appropriate by their preceptors. PGY-2 pharmacy residents will join a subcommittee that is deemed appropriate by the respective residency director.
The resident will receive a midpoint evaluation, a minimum of two criteria-based snapshots and a summative evaluation for each rotation. As a self-evaluation, the resident will complete a summative evaluation and snapshots as assigned per preceptor. The resident will also complete a preceptor/learning experience evaluation.
All residents will assist the pharmacy department in actively recruiting talented professionals by participating in various events. Events include, but are not limited to: St. John's University College of Pharmacy Residency Showcase, ASHP Midyear Clinical Meeting, and on-site interviews of candidates for the next year's residency class.
Verification of Licensure
All residents are required to obtain a New York State pharmacy intern permit prior to the start of the residency program. Residents are also required to receive New York State licensure by:
- Completing Part III of New York State boards (compounding exam) in June prior to the start of the residency year or equivalent alternative at the start of the residency program.
- Completing NABPLEX and New York State MPJE law by September 30th and becoming licensed by December 31st of the residency year.
Residents who fail to pass Part III of the New York State Boards in June, or residents accepted through the post-match will be required to pass the exam in January of the following year and must be licensed in the State of New York by March 31st of their residency year.
Failure to comply with these requirements will result in termination from the residency program and NYP.
The resident's primary commitment is the residency program and thus, work outside of the residency program is strongly discouraged. Employment outside of the residency program is conditional based on a resident's satisfactory fulfillment of all residency obligations.
Weekend Clinical Coverage
PGY-1 pharmacy residents are expected to be on-site at their assigned institution for 7.5 hours each day every second weekend. However, as patient care workload dictates, additional time may be required to complete all assigned duties each weekend. Residents are required to sign in at the start of their day. Duties are as follows:
- Pharmacy Operations. Residents are assigned to work in a pharmacy satellite that will be conducive to the development of a functional knowledge base of how to process orders, prepare intravenous medications, refill medication carts, and compound medications.
- Drug Information Coverage. Residents are required to answer any drug information questions that come up during their weekend on-call. All responses must be reviewed with the clinical staff member on-call prior to contacting the prescriber.
- Pharmacokinetic Monitoring. Residents are required to evaluate new patients and follow-up on patients requiring therapeutic drug monitoring.
- Transplant Discharge Education Program. Transplant patients are assigned based on the site the resident is covering. Residents provide discharge medication education to patients and families.
- Projects. Residents may work on their projects, as time allows.
PGY-2 pharmacy residents are expected to be on-site at their assigned institution for 7.5 hours every other Saturday. Residents are required to sign in at the start of their day. Duties will be specific to the program.
Requests for Time Off
Following approval by the rotation preceptor, requests for time off must be made in writing by completing the Pharmacy Department Vacation, Holiday and Compensatory Time Request Form and approved by the Residency Director. Requests for extended time off must be turned in to the Residency Director a minimum of 4 weeks before the requested date. Residents who need to take an extended leave of absence (greater than one week) from the residency program may be required to extend their residency past the official date of residency completion in order to complete their rotations, projects and satisfy all ASHP requirements. Extended leaves of absence will be assessed by the Residency Advisory Committee and a decision will be made by the Residency Program Director on a case by case basis. Emergency situations, such as sick days, require prompt notification of the Residency Director and rotation preceptor to ensure patient services are covered during unexpected absences.